IRCCS Ospedale Policlinico San Martino at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

IRCCS Ospedale Policlinico San Martino brings 3 presentations to ISLB 2026 in Madrid. Its work looks for blood and pleural fluid markers of treatment outcome and immune patterns in breast cancer, lung cancer and pleural mesothelioma. One study tests whether soluble TIM3 signals acquired resistance to immune checkpoint therapy in metastatic non-small-cell lung cancer.

OrganizationISLB 2026 Attendance
ospedalesanmartino.it
Hospitals & cancer centres
Public research hospital in Genoa and teaching hospital of the University of Genoa.
Poster
Part of Poster sessions
Clonal Hematopoiesis in Early Breast Cancer: A Pilot Study on Treatment Toxicity and Clinical Outcomes
Clinical use
Collaborators: Fondazione Edo ed Elvo Tempia
Poster
Part of Poster sessions
Plasma and Pleural Effusion Profiling Reveals Histotype-related Immune Patterns in Pleural Mesothelioma
Clinical use · Pre-analytics
Poster

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from IRCCS Ospedale Policlinico San Martino

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction